Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 54, Issue 1, Pages 15-19Publisher
SPRINGER
DOI: 10.1007/s11239-022-02657-x
Keywords
Platelets; Stable coronary artery disease; Clopidogrel; Circadian rhythm; Platelet reactivity
Ask authors/readers for more resources
This study found that platelet reactivity in patients receiving elective PCI and clopidogrel treatment exhibits diurnal variations, with the highest platelet reactivity observed in the morning. This has important implications for improving the durability and consistency of antiplatelet inhibition.
Evidence assessing potential diurnal variations of platelet reactivity in patients on clopidogrel treated with elective percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) are currently lacking. We prospectively enrolled 15 patients affected by stable coronary artery disease (CAD) previously treated with elective PCI and on clopidogrel for at least 8 days (administered at 8 a.m.). A significant heterogeneity in diurnal levels of ADP-dependent platelet aggregation was found (p = 0.0004), with a peak of platelet reactivity occurring at the 6 a.m. assessment, which resulted significantly increased compared to the afternoon (6 p.m.) evaluation (255 +/- 66 vs 184 +/- 67, p = 0.002). In addition, at the early-morning evaluation a considerably high proportion of patients with high platelet reactivity (53.3%) were observed. In conclusion, clopidogrel-induced platelet inhibition in patients with CCS after elective PCI follows a circadian rhythm, thus suggesting that a consistent and durable antiplatelet inhibition is often failed with standard clopidogrel administration at morning.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available